London, United Kingdom

David Trevor Collin


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • London, EN (1977 - 1978)
  • London, GB (1978)

Company Filing History:


Years Active: 1977-1978

Loading Chart...
3 patents (USPTO):Explore Patents

Title: David Trevor Collin: Innovator in Pharmaceutical Chemistry

Introduction

David Trevor Collin is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 3 patents to his name, Collin has focused on developing compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, Collin has developed Phenethanolamine ethers, which are compounds of the general formula I and physiologically acceptable acid addition salts thereof. These compounds feature R.sup.1 as a lower alkyl, lower alkenyl, or arylalkyl radical, which may optionally be substituted by one or more alkoxy or hydroxy groups. Another significant patent is for Phenylaminoethanol derivatives aimed at treating hypertension, which includes compounds of a specific formula and their physiologically acceptable acid addition salts.

Career Highlights

Collin's career is marked by his work at Allen Hanburys Limited, where he has been instrumental in advancing pharmaceutical research and development. His innovative spirit and dedication to improving health outcomes through chemistry have made him a respected figure in his field.

Collaborations

Throughout his career, Collin has collaborated with notable colleagues, including Lawrence Henry Lunts and David Hartley. These collaborations have further enriched his work and contributed to the success of his inventions.

Conclusion

David Trevor Collin stands out as a significant inventor in the realm of pharmaceutical chemistry, with a focus on innovative compounds that address critical health issues. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…